Plasmacure is a Dutch MedTech company and we envision a world where people no longer suffer from chronic wounds. For our CE certified PLASOMA cold plasma system, we are shaping the international commercial roll-out.

Interview 5 July 2022 Patient Sheila MacLeod and Monique van Gerwen, wound and pressure ulcer consultant at Máxima MC in Veldhoven talk about the poorly healing surgical wound after amputation of a toe.

Globally, 140 million people have chronic wounds. Wounds that are difficult to heal have a major impact on quality of life. Plasmacure has developed a unique and patented solution based on cold plasma to address this problem: PLASOMA.

As head of the wound center of Alrijne Hospital (surgery department) and one of the principal investigators in a clinical study with PLASOMA of Plasmacure, Wouter has been focusing on wound care since 2010.

Interview 29th March 2022 “For 10 years I was unaware that I had diabetes. That really took its toll on my body. Due to neuropathy, a type of nerve damage, I lost feeling in my lower legs.

25 March 2022  – Author: Petra Teunissen. This article was published in the professional journal VoetVak+ for medical and cosmetic foot care.  Infection is one of the most common complications of poorly healing wounds.

Werd van der Horst, diabetes patient: promising treatment with PLASOMA Patient Werd van der Horst and Ingrid Ruys, diabetes podiatrist Máxima MC in Veldhoven, talk about the treatment of a large hole between the first and fourth toe of Werd’s foot.

This article describes the Tv-broadcast (in Dutch) of October 30, 2021, episode 303. At the end of this news item you will find a link to an English subtitled video about patient Werd van der Horst and diabetes podiatrist Ingrid Ruys.

Medtech start-up Plasmacure is developing an innovative plaster to treat chronically open wounds. Sixty percent are healed within seven weeks. 23 December 2021 – Author: Corine Spaans, published by Innovation Origins.